XO4

(5S)-5-butyl-4-({1-[(4-fluorophenyl)methyl]-1H-imidazol-5-yl}methyl)-1-[3-(trifluoromethoxy)phenyl]piperazin-2-one

Created:	2020-12-22
Last modified:	2022-11-09

Find Related PDB Entry
1 entries where XO4 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	64
Chiral Atom Count	1
Bond Count	67
Aromatic Bond Count	17

2D diagram of XO4

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(5S)-5-butyl-4-({1-[(4-fluorophenyl)methyl]-1H-imidazol-5-yl}methyl)-1-[3-(trifluoromethoxy)phenyl]piperazin-2-one
Systematic Name (OpenEye OEToolkits)	(5~{S})-5-butyl-4-[[3-[(4-fluorophenyl)methyl]imidazol-4-yl]methyl]-1-[3-(trifluoromethyloxy)phenyl]piperazin-2-one
Formula	C₂₆ H₂₈ F₄ N₄ O₂
Molecular Weight	504.52
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	C2C(=O)N(c1cc(ccc1)OC(F)(F)F)CC(CCCC)N2Cc3n(cnc3)Cc4ccc(F)cc4
SMILES	CACTVS	3.385	CCCC[CH]1CN(C(=O)CN1Cc2cncn2Cc3ccc(F)cc3)c4cccc(OC(F)(F)F)c4
SMILES	OpenEye OEToolkits	2.0.7	CCCCC1CN(C(=O)CN1Cc2cncn2Cc3ccc(cc3)F)c4cccc(c4)OC(F)(F)F
Canonical SMILES	CACTVS	3.385	CCCC[C@H]1CN(C(=O)CN1Cc2cncn2Cc3ccc(F)cc3)c4cccc(OC(F)(F)F)c4
Canonical SMILES	OpenEye OEToolkits	2.0.7	CCCC[C@H]1CN(C(=O)CN1Cc2cncn2Cc3ccc(cc3)F)c4cccc(c4)OC(F)(F)F
InChI	InChI	1.03	InChI=1S/C26H28F4N4O2/c1-2-3-5-22-16-34(21-6-4-7-24(12-21)36-26(28,29)30)25(35)17-32(22)15-23-13-31-18-33(23)14-19-8-10-20(27)11-9-19/h4,6-13,18,22H,2-3,5,14-17H2,1H3/t22-/m0/s1
InChIKey	InChI	1.03	OUYZKEOWZZQKSB-QFIPXVFZSA-N

Related Resource References

Resource Name	Reference
PubChem	165416317

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.